The Rise, Bankruptcy and Rebirth of 23andMe | The Circuit
Emily Chang meets 23andMe Institute Chief Executive Officer Anne Wojcicki for a discussion of the rise, fall and rebirth of ...
Wednesday, July 15, 2026
Tag: Genetics
rewrite this title and make it good for SEOWhy the federal hemp THC ban is bad news for cannabis genetics
rewrite this content using a minimum of 1000 words and keep HTML tags The bill ushering in federal hemp THC ...
Xenotransplants: Human Receives Gene-edited Pig Kidney
Biotech company eGenesis recently announced its second patient implanted with a pig kidney. This animal-to-human organ transplant, or xenotransplant, was ...
What Happened To 23andMe?
23andMe was one of the hottest startups of the 2000s, once valued at $6 billion. The company’s DNA test kits ...
Morgan Stanley predicts that Myriad Genetics’ stock potential growth depends on its hereditary cancer segment.
On Thursday, Morgan Stanley initiated coverage on Myriad Genetics (NASDAQ:) stock, a prominent genetic testing provider, with an Equalweight rating ...
- Trending
- Comments
- Latest
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.